Who owns VISTAGEN THERAPEUTICS ORD?
- Ticker: VTGN
- CUSIP Number: 92840h400
Tip: Access positions for across all investors
Analyze quarterly positions in Vistagen Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Vistagen Therapeutics Ord stock
Who bought or sold VISTAGEN THERAPEUTICS ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| OrbiMed Advisors | 3.1M | $1.7M | -1% | Mar 2026 |
|
| TCG Crossover Management | 2.7M | $1.5M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 1.6M | $900k | 100% | Mar 2026 |
|
| ADAR1 Capital Management | 751k | $429k | 1% | Mar 2026 |
|
| Millennium Management | 644k | $368k | 227% | Mar 2026 |
|
| Stempoint Capital | 617k | $58k | 0% | Mar 2026 |
|
| Acadian Asset Management | 590k | $336k | 100% | Mar 2026 |
|
| Ikarian Capital | 519k | $297k | 0% | Mar 2026 |
|
| Two Sigma Investments | 470k | $268k | 140% | Mar 2026 |
|
| Geode Capital Management | 453k | $259k | 28% | Mar 2026 |
|
| BlackRock | 449k | $256k | 6% | Mar 2026 |
|
| Luminus Management | 396k | $226k | 13% | Mar 2026 |
|
| Jane Street | 296k | $169k | -51% | Mar 2026 |
|
| Renaissance Technologies | 291k | $167k | 81% | Mar 2026 |
|
| AdvisorShares Investments | 277k | $158k | 11% | Mar 2026 |
|
| Citadel Advisors | 275k | $157k | -68% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 218k | $125k | 100% | Mar 2026 |
|
| Verdad Advisers | 185k | $106k | 100% | Mar 2026 |
|
| Susquehanna International | 183k | $105k | -78% | Mar 2026 |
|
| XTX Topco | 153k | $87k | 100% | Mar 2026 |
|
| Shay Capital | 145k | $83k | 100% | Mar 2026 |
|
| Boothbay Fund Management | 135k | $77k | 0% | Mar 2026 |
|
| State Street Corporation | 121k | $69k | 0% | Mar 2026 |
|
| Tudor Investment Corporation | 106k | $61k | 39% | Mar 2026 |
|
| Diadema Partners | 105k | $60k | -49% | Mar 2026 |
|
| Simplex Trading | 90k | $51k | 100% | Mar 2026 |
|
| UBS Group | 79k | $45k | 51% | Mar 2026 |
|
| Northern Trust | 73k | $42k | 0% | Mar 2026 |
|
| Prudential Financial | 53k | $30k | 100% | Mar 2026 |
|
| GSA Capital Partners | 50k | $28k | 100% | Mar 2026 |
|
| Persistent Asset Partners | 27k | $15k | 0% | Mar 2026 |
|
| Schonfeld Strategic Advisors | 27k | $15k | 22% | Mar 2026 |
|
| Kestra Advisory Services | 26k | $15k | 0% | Mar 2026 |
|
| Hrt Financial | 25k | $14k | -32% | Mar 2026 |
|
| HighTower Advisors | 21k | $12k | 0% | Mar 2026 |
|
| Group One Trading | 20k | $11k | -81% | Mar 2026 |
|
| Truvestments Capital | 17k | $9.7k | 0% | Mar 2026 |
|
| Two Sigma Securities | 17k | $9.4k | 100% | Mar 2026 |
|
| Intl Fcstone | 15k | $8.7k | 14% | Mar 2026 |
|
| Farther Finance Advisors | 15k | $3.4k | 100% | Jun 2026 |
|
| Raymond James Financial | 15k | $8.5k | 100% | Mar 2026 |
|
| Caption Management | 15k | $8.4k | -81% | Mar 2026 |
|
| Vanguard Global Advisers | 11k | $6.2k | 100% | Mar 2026 |
|
| Performa | 7.5k | $4.3k | 650% | Mar 2026 |
|
| Advisor Group Holdings | 4.1k | $2.4k | -22% | Mar 2026 |
|
| Royal Bank of Canada | 2.1k | $999.902700 | 100% | Mar 2026 |
|
| Tower Research Capital | 1.6k | $897.926400 | -82% | Mar 2026 |
|
| Annis Gardner Whiting Capital Advisors | 600.00 | $343.020000 | 100% | Mar 2026 |
|
| CWM | 582.00 | $333.020400 | 0% | Mar 2026 |
|
| MAI Wealth Advisors | 526.00 | $300.977200 | 0% | Mar 2026 |
|
| SBI Securities | 288.00 | $164.995200 | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 114.00 | $65.002800 | 0% | Mar 2026 |
|
| Fairman Group | 29.00 | $16.999800 | 0% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 16.00 | $9.000000 | 100% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 13.00 | $7.000500 | 0% | Mar 2026 |
|
| Citigroup | 1.00 | $1.000000 | 100% | Mar 2026 |
|
| Morgan Stanley | 1.00 | $1.000000 | -100% | Mar 2026 |
|
Who sold out of Vistagen Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Dimensional Fund Advisors | Dec 2025 | 152k | $101k |
| Two Sigma Advisers | Dec 2025 | 138k | $91k |
| OMERS Administration Corporation | Dec 2025 | 103k | $68k |
| Seven Fleet Capital Management | Dec 2025 | 63k | $42k |
| Qube Research & Technologies | Dec 2025 | 60k | $40k |
| Occudo Quantitative Strategies | Dec 2025 | 59k | $39k |
| American Century Companies | Dec 2025 | 49k | $32k |
| Virtu Financial | Dec 2025 | 38k | $25k |
| Engineers Gate Manager | Dec 2025 | 31k | $20k |
| Charles Schwab Investment Management | Dec 2025 | 23k | $15k |
| Lighthouse Investment Partners | Dec 2025 | 21k | $14k |
| None | Dec 2025 | 20k | $13k |
| Marshall Wace | Dec 2025 | 20k | $13k |
| DRW Holdings | Dec 2025 | 10k | $6.6k |